Metastatic Gastroesophageal Junction Adenocarcinoma

DrugDrug NameDrug Description
DB09035NivolumabA PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma.
DB09343TipiracilA thymidine phosphorylase inhibitor used as an adjunct treatment of adult patients with certain types of gastric or colorectal malignancies.
DB00072TrastuzumabA monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers.
DB00432TrifluridineA nucleoside metabolic inhibitor used to treat keratoconjunctivitis and epithelial keratitis caused by simplex virus, and as a part of chemotherapy for certain types of metastatic gastrointestinal cancers.
DrugDrug NamePhaseStatusCount
DB09078Lenvatinib0Recruiting1
DB09037Pembrolizumab0Completed1
DB09037Pembrolizumab0Recruiting1
DB11740Adavosertib1Active Not Recruiting1
DB01373Calcium1Active Not Recruiting1
DB04690Camptothecin1Active Not Recruiting1
DB14917Ceralasertib1Recruiting1
DB00531Cyclophosphamide1Recruiting1
DB00544Fluorouracil1Active Not Recruiting1
DB12413Indusatumab vedotin1Terminated1
DB00762Irinotecan1Active Not Recruiting1
DB00650Leucovorin1Active Not Recruiting1
DB11596Levoleucovorin1Active Not Recruiting1
DB01229Paclitaxel1Active Not Recruiting1
DB09037Pembrolizumab1Recruiting2
DB00020Sargramostim1Recruiting1
DB09143Sonidegib1Recruiting1
DB08937TAS-1021Recruiting1
DB11760Talazoparib1Recruiting1
DB04485Thymidine1Recruiting1
DB09343Tipiracil1Recruiting1
DB14962Trastuzumab deruxtecan1Recruiting1
DB00432Trifluridine1Recruiting1
DB12001Abemaciclib1 / 2Not Yet Recruiting1
DB01373Calcium1 / 2Active Not Recruiting1
DB00531Cyclophosphamide1 / 2Completed1
DB00544Fluorouracil1 / 2Active Not Recruiting1
DB11679Fruquintinib1 / 2Recruiting1
DB05643IRX-21 / 2Completed1
DB00762Irinotecan1 / 2Active Not Recruiting1
DB00762Irinotecan1 / 2Withdrawn1
DB00650Leucovorin1 / 2Active Not Recruiting1
DB11596Levoleucovorin1 / 2Active Not Recruiting1
DB06599Lexatumumab1 / 2Active Not Recruiting1
DB09074Olaparib1 / 2Active Not Recruiting1
DB09037Pembrolizumab1 / 2Completed1
DB05578Ramucirumab1 / 2Active Not Recruiting1
DB05578Ramucirumab1 / 2Not Yet Recruiting1
DB05578Ramucirumab1 / 2Withdrawn1
DB12332Rucaparib1 / 2Active Not Recruiting1
DB15765Sintilimab1 / 2Recruiting1
DB00072Trastuzumab1 / 2Active Not Recruiting1
DB15676Balstilimab2Recruiting1
DB11794Berzosertib2Active Not Recruiting1
DB16651Botensilimab2Recruiting1
DB14776Camrelizumab2Not Yet Recruiting1
DB14776Camrelizumab2Recruiting1
DB05759Cixutumumab2Active Not Recruiting1
DB12250Cixutumumab2Active Not Recruiting1
DB12109Devimistat2Recruiting1
DB01248Docetaxel2Recruiting2
DB00544Fluorouracil2Recruiting3
DB00441Gemcitabine2Recruiting1
DB01611Hydroxychloroquine2Recruiting1
DB00762Irinotecan2Active Not Recruiting1
DB00650Leucovorin2Recruiting1
DB06599Lexatumumab2Recruiting1
DB00166Lipoic acid2Recruiting1
DB00526Oxaliplatin2Recruiting2
DB01229Paclitaxel2Active Not Recruiting1
DB01229Paclitaxel2Recruiting2
DB09037Pembrolizumab2Recruiting1
DB00571Propranolol2Recruiting1
DB05578Ramucirumab2Recruiting2
DB14765Rivoceranib2Not Yet Recruiting1
DB14765Rivoceranib2Recruiting1
DB08937TAS-1022Recruiting1
DB09343Tipiracil2Recruiting1
DB00432Trifluridine2Recruiting1
DB06599Lexatumumab2 / 3Not Yet Recruiting1
DB09035Nivolumab2 / 3Not Yet Recruiting1
DB01229Paclitaxel2 / 3Not Yet Recruiting1
DB05578Ramucirumab2 / 3Not Yet Recruiting1
DB00544Fluorouracil3Recruiting1
DB00762Irinotecan3Recruiting1
DB00650Leucovorin3Recruiting1
DB09035Nivolumab3Recruiting1
DB00526Oxaliplatin3Recruiting1